Susquehanna International Group, LLP I Mab Put Options Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
Put Options
1 transactions
Others Institutions Holding IMAB
# of Institutions
38Shares Held
13.8MCall Options Held
20KPut Options Held
13.3K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$5.62 Million0.15% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$3.92 Million3.04% of portfolio
-
Sg Americas Securities, LLC822KShares$772,7180.0% of portfolio
-
Stonepine Capital Management, LLC Bend, OR484KShares$454,6280.39% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny363KShares$341,4080.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $78.1M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...